Daré Bioscience, Inc.DARENASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank87
3Y CAGR-24.0%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-24.0%/yr
vs +162.2%/yr prior
Acceleration
-186.2pp
Decelerating
Percentile
P87
Within normal range
vs 3Y Ago
0.4x
Contraction
Streak
2 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | 88.28% |
| Q2 2025 | 6.46% |
| Q1 2025 | -220.67% |
| Q4 2024 | 182.67% |
| Q3 2024 | -144.71% |
| Q2 2024 | 285.03% |
| Q1 2024 | 22.38% |
| Q4 2023 | -9.88% |
| Q3 2023 | -21.40% |
| Q2 2023 | 59.14% |
| Q1 2023 | -173.21% |
| Q4 2022 | -169.04% |
| Q3 2022 | 201.14% |
| Q2 2022 | 31.57% |
| Q1 2022 | -24.53% |
| Q4 2021 | -859.37% |
| Q3 2021 | 111.07% |
| Q2 2021 | -40.76% |
| Q1 2021 | 8.91% |
| Q4 2020 | -71.67% |
| Q3 2020 | -30.58% |
| Q2 2020 | 37.82% |
| Q1 2020 | -73.22% |
| Q4 2019 | -19.77% |
| Q3 2019 | -5.36% |
| Q2 2019 | 8.77% |
| Q1 2019 | 77.25% |
| Q4 2018 | -428.03% |
| Q3 2018 | -2.12% |
| Q2 2018 | -27.28% |
| Q1 2018 | -120.47% |
| Q4 2017 | -106.95% |
| Q3 2017 | 355.48% |
| Q2 2017 | 45.84% |
| Q1 2017 | -423.29% |
| Q4 2016 | 73.41% |
| Q3 2016 | 36.70% |
| Q2 2016 | 16.63% |
| Q1 2016 | -63.18% |
| Q4 2015 | -4.31% |